In order to test the central hypothesis of the study in a more clinically relevant model, the therapeutic response of breast tumors expressing low versus high levels of Cks2 to combination treatment with methotrexate and gemcitabine was analyzed in an orthotopic mouse model. The gene discussed is CKS2; the disease is breast neoplasm.